AN ACT TO AMEND SECTION 41-137-3, MISSISSIPPI CODE OF 1972, TO REVISE THE DEFINITION OF "QUALIFYING PATIENT" TO INCLUDE A PERSON FOR WHOM A PRACTITIONER HAS DETERMINED, AFTER CONVENTIONAL TREATMENT OPTIONS HAVE PROVEN INEFFECTIVE, THAT THE PATIENT MAY BENEFIT FROM MEDICAL CANNABIS; TO AMEND SECTION 41-137-5, MISSISSIPPI CODE OF 1972, TO AUTHORIZE MEDICAL CANNABIS USE BY A PERSON DIAGNOSED BY A PRACTITIONER, WITH WHOM THE PERSON HAS A BONA FIDE PRACTITIONER-PATIENT RELATIONSHIP WITHIN HIS OR HER SCOPE OF PRACTICE, AS A PATIENT FOR WHOM OTHER CONVENTIONAL TREATMENT OPTIONS HAVE PROVEN INEFFECTIVE; AND FOR RELATED PURPOSES.
Impact
The implications of SB2438 are significant for state law as it alters the criteria under which individuals can obtain medical cannabis. By expanding the qualifying conditions to include those for whom traditional treatments have failed, it potentially increases the patient population eligible for medical marijuana. This may foster greater reliance on cannabis as part of treatment protocols and modify the standard practices of healthcare providers in assessing and certifying patients.
Summary
Senate Bill 2438 proposes amendments to the Mississippi Medical Cannabis Act to broaden the definition of a 'qualifying patient'. It stipulates that individuals diagnosed with a debilitating medical condition, who have not found success with conventional treatments, may be eligible for medical cannabis therapy. The bill emphasizes the importance of a bona fide practitioner-patient relationship, requiring that practitioners conduct thorough assessments and document patient needs in medical records. This change aims to make medical cannabis more accessible to patients suffering from serious health conditions.
Contention
However, the bill may face contention regarding the expansion of cannabis use. Opponents may argue that the broadening of qualifying criteria could lead to increased cannabis consumption and misuse. Furthermore, concerns about the adequacy of practitioner training in assessing alternative treatments and managing medical cannabis prescriptions may arise. There could be a push for ensuring adequate oversight and regulation by the Mississippi Department of Health to prevent possible abuse of this expanded access.